The crackdown that began in late 2023 saw nearly twenty of the most popular peptides, such as BPC-157 and Thymosin Alpha-1, abruptly moved to Category 2
Treatment was associated with fibrosis improvement by at least one stage with no worsening in non-alcoholic fatty liver disease (NAFLD) activity score in 25% of resmetirom recipients versus just under 15% in the placebo group
This review paper highlights preclinical and clinical studies indicating that GLP-1 drugs, including low dose formulations such as exenatide, may offer neuroprotective benefits by targeting hallmarks of brain aging through enhancing DNA repair, boosting antioxidant responses, reducing inflammation and improving mitochondrial function
Semaglutide partially improved islet morphology, whereas tirzepatide offered little benefit
I wish some of the others were a bit less but happy
When you escalate from 0.5 mg to 1.0 mg of semaglutide, for example, the nausea pattern may reset